{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:18:34Z","timestamp":1787840314835,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Opportunistic fungal infections are associated with patients having compromised systemic health. In India, a slow rise in cases of mucormycosis has been observed as the country has seen a rising number of diabetes mellitus cases in the recent decades. This apart, an enormous increase in case numbers was seen in association with COVID-19 infections in the Asian subcontinent, Southeast Asia, markedly in India. Many cases of mucormycosis were reported in association with COVID-19 positive history and post-treatment for COVID-19. They were presented in the form of rhino-cerebral-mucormycosis, in patients with and without diabetes. The presentation of the disease differed at different times of the pandemic to some extent. Some of the cases initially came in an acute format, but at the later end of the epidemic, they presented in an indolent form. A compilation of cases is provided to illustrate the variation in presentations and findings of mucormycosis cases diagnosed at different times of infection of the COVID-19 waves.<\/jats:p>","DOI":"10.4103\/jomfp.jomfp_236_24","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T02:01:21Z","timestamp":1728957681000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["MUCORMYCOSIS: Re-emerging opportunistic fungal infections in COVID-19 pandemic times in Indian patients (South Indian) \u2013 A series of seven cases"],"prefix":"10.4103","volume":"28","author":[{"given":"Satyajit S.","family":"Topajiche","sequence":"first","affiliation":[{"name":"Consultant Oral and Maxillofacial Pathologist, Care Oral Pathology Services, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasoon S.","family":"Babu","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial Surgeon, Private Practitioner, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Consultant Cranio-Maxillofacial Surgeon, Bhagwan Mahaveer Jain Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Phani","family":"Raghava","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial Surgeon, Private Practitioner, Ananthapur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"R1-20241016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12223-021-00934-5","article-title":"Mucormycosis: Risk factors, diagnosis, treatments, and challengesduring COVID-19 pandemic","volume":"67","author":"Sharma","year":"2022","journal-title":"Folia Microbiol"},{"key":"R2-20241016","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med Mycol"},{"key":"R3-20241016","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"},{"key":"R4-20241016","first-page":"e18827","article-title":"Risk of mucormycosis in diabetes mellitus: A systematic review","volume":"13","author":"Khanna","year":"2021","journal-title":"Cureus"},{"key":"R5-20241016","first-page":"987","article-title":"Rhinocerebral mucormycosis: An update","volume":"14","author":"Mallis","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R6-20241016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2006.01604.x","article-title":"Mucormycosis: An emerging disease?","volume":"12","author":"Bouza","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R7-20241016","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: An Update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi"},{"key":"R9-20241016","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"R10-20241016","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1038\/s41598-022-13443-3","article-title":"COVID-19 associated mucormycosis in Assiut University Hospitals: A multidisciplinary dilemma","volume":"12","author":"Youssif","year":"2022","journal-title":"Sci Rep"},{"key":"R11-20241016","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","article-title":"Diabetes and mucormycosis: A complex interplay","volume":"38","author":"Rammaert","year":"2012","journal-title":"Diabetes Metab"},{"key":"R12-20241016","article-title":"A rare indolent course of rhinocerebral mucormycosis","author":"Khudyakov","year":"2021","journal-title":"Case Rep Infect Dis 2021"},{"key":"R13-20241016","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India","volume":"15","author":"Mishra","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R14-20241016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-021-06625-3","article-title":"A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: A systematic review of literature and current update","volume":"21","author":"Mohammadi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R15-20241016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/postgradmedj-2021-140537","article-title":"Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India","volume":"98","author":"Banerjee","year":"2022","journal-title":"Postgrad Med J"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_236_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:20:08Z","timestamp":1787836808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_236_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_236_24","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-08-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}